Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Keramidas

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Biomedical Optics|October 12, 2012
FluoSTIC: miniaturized fluorescence image-guided surgery systemSylvain Gioux, Jean-Guillaume Coutard, Michel Berger, et al.
Oncotarget|June 4, 2015
IPP51, a chalcone acting as a microtubule inhibitor with in vivo antitumor activity against bladder carcinomaVéronique Martel-Frachet, Michelle Keramidas, Alessandra Nurisso, et al.
Circulation Research|March 1, 2008
Bone morphogenetic protein-9 is a circulating vascular quiescence factorLaurent David, Christine Mallet, Michelle Keramidas, et al.
Antimicrobial Agents and Chemotherapy|September 10, 2009
Pharmacological inhibition of transforming growth factor beta signaling decreases infection and prevents heart damage in acute Chagas' diseaseMariana C Waghabi, Elen M de Souza, Gabriel M de Oliveira, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 29, 2023
RGD-Based Fluorescence to Assess Placental AngiogenesisVeronique Josserand, Jonathan Lavaud, Michelle Keramidas, et al.
Oncotarget|March 7, 2015
A new chemical inhibitor of angiogenesis and tumorigenesis that targets the VEGF signaling pathway upstream of RasAgnès Desroches-Castan, Delphine Quélard, Martine Demeunynck, et al.
The Journal of Infectious Diseases|November 26, 2002
Implication of transforming growth factor-beta1 in Chagas disease myocardiopathyTania C Araújo-Jorge, Mariana C Waghabi, Alejandro M Hasslocher-Moreno, et al.
Antimicrobial Agents and Chemotherapy|May 29, 2007
SB-431542, a transforming growth factor beta inhibitor, impairs Trypanosoma cruzi infection in cardiomyocytes and parasite cycle completionMariana C Waghabi, Michelle Keramidas, Claudia M Calvet, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 11, 2014
Self-assembled biotransesterified cyclodextrins as potential Artemisinin nanocarriers. II: In vitro behavior toward the immune system and in vivo biodistribution assessment of unloaded nanoparticlesJosias B G Yaméogo, Annabelle Gèze, Luc Choisnard, et al.
The American Journal of Pathology|September 30, 2005
Uptake of host cell transforming growth factor-beta by Trypanosoma cruzi amastigotes in cardiomyocytes: potential role in parasite cycle completionMariana C Waghabi, Michelle Keramidas, Sabine Bailly, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Biomedical Optics|October 12, 2012
FluoSTIC: miniaturized fluorescence image-guided surgery systemSylvain Gioux, Jean-Guillaume Coutard, Michel Berger, et al.
Oncotarget|June 4, 2015
IPP51, a chalcone acting as a microtubule inhibitor with in vivo antitumor activity against bladder carcinomaVéronique Martel-Frachet, Michelle Keramidas, Alessandra Nurisso, et al.
Circulation Research|March 1, 2008
Bone morphogenetic protein-9 is a circulating vascular quiescence factorLaurent David, Christine Mallet, Michelle Keramidas, et al.
Antimicrobial Agents and Chemotherapy|September 10, 2009
Pharmacological inhibition of transforming growth factor beta signaling decreases infection and prevents heart damage in acute Chagas' diseaseMariana C Waghabi, Elen M de Souza, Gabriel M de Oliveira, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 29, 2023
RGD-Based Fluorescence to Assess Placental AngiogenesisVeronique Josserand, Jonathan Lavaud, Michelle Keramidas, et al.
Oncotarget|March 7, 2015
A new chemical inhibitor of angiogenesis and tumorigenesis that targets the VEGF signaling pathway upstream of RasAgnès Desroches-Castan, Delphine Quélard, Martine Demeunynck, et al.
The Journal of Infectious Diseases|November 26, 2002
Implication of transforming growth factor-beta1 in Chagas disease myocardiopathyTania C Araújo-Jorge, Mariana C Waghabi, Alejandro M Hasslocher-Moreno, et al.
Antimicrobial Agents and Chemotherapy|May 29, 2007
SB-431542, a transforming growth factor beta inhibitor, impairs Trypanosoma cruzi infection in cardiomyocytes and parasite cycle completionMariana C Waghabi, Michelle Keramidas, Claudia M Calvet, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 11, 2014
Self-assembled biotransesterified cyclodextrins as potential Artemisinin nanocarriers. II: In vitro behavior toward the immune system and in vivo biodistribution assessment of unloaded nanoparticlesJosias B G Yaméogo, Annabelle Gèze, Luc Choisnard, et al.
The American Journal of Pathology|September 30, 2005
Uptake of host cell transforming growth factor-beta by Trypanosoma cruzi amastigotes in cardiomyocytes: potential role in parasite cycle completionMariana C Waghabi, Michelle Keramidas, Sabine Bailly, et al.
Pageof 3